Cargando…
Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma
Neuroendocrine carcinoma of the cervix is a rare subtype of cervical cancer with a poor prognosis. Primary treatment of this disease involves a combination of surgery, chemotherapy, and radiation. The majority of patients will experience disease recurrence, for which there exist no treatment guideli...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284394/ https://www.ncbi.nlm.nih.gov/pubmed/35846558 http://dx.doi.org/10.1016/j.gore.2022.101039 |